Literature DB >> 6852169

Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors.

T Hadley, M Aikawa, L H Miller.   

Abstract

The effect of protease inhibitors on invasion of rhesus erythrocytes by Plasmodium knowlesi merozoites was evaluated. Chymostatin, N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK), and L-1-tosylamide-2-phenylethylchloromethyl ketone (TPCK) inhibited invasion. Leupeptin, antipain, pepstatin, and phenylmethylsulfonyl fluoride (PMSF) had no effect. TLCK and TPCK inhibited attachment of merozoites to host erythrocytes. Chymostatin had no adverse effect on attachment, and in its presence junction formation between the merozoite and host erythrocyte occurred. Both chymostatin and leupeptin inhibited normal rupture of schizont-infected erythrocytes. It is suggested that proteolytic activity may be important both in the rupture of schizont-infected erythrocytes and in the invasion of erythrocytes by malaria parasites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852169     DOI: 10.1016/0014-4894(83)90027-9

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  29 in total

1.  Looking for the exit: How do malaria parasites escape from red blood cells?

Authors:  L H Bannister
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

2.  Plasmodium chabaudi p68 serine protease activity required for merozoite entry into mouse erythrocytes.

Authors:  C B Breton; T Blisnick; H Jouin; J C Barale; T Rabilloud; G Langsley; L H Pereira da Silva
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Authors:  Puran S Sijwali; Kentaro Kato; Karl B Seydel; Jiri Gut; Julie Lehman; Michael Klemba; Daniel E Goldberg; Louis H Miller; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

4.  Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.

Authors:  Michelle J Boyle; Danny W Wilson; Jack S Richards; David T Riglar; Kevin K A Tetteh; David J Conway; Stuart A Ralph; Jake Baum; James G Beeson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

5.  The malaria parasite progressively dismantles the host erythrocyte cytoskeleton for efficient egress.

Authors:  Melanie G Millholland; Rajesh Chandramohanadas; Angel Pizzarro; Angela Wehr; Hui Shi; Claire Darling; Chwee Teck Lim; Doron C Greenbaum
Journal:  Mol Cell Proteomics       Date:  2011-09-08       Impact factor: 5.911

6.  Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

Authors:  P S Sijwali; B R Shenai; J Gut; A Singh; P J Rosenthal
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

7.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Purification and identification of a neutral endopeptidase in Plasmodium falciparum schizonts and merozoites.

Authors:  P Grellier; I Picard; F Bernard; R Mayer; H G Heidrich; M Monsigny; J Schrével
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  Studies on synchronous egress of coccidian parasites (Neospora caninum, Toxoplasma gondii, Eimeria bovis) from bovine endothelial host cells mediated by calcium ionophore A23187.

Authors:  Jan H Behrendt; Anja Taubert; Horst Zahner; Carlos Hermosilla
Journal:  Vet Res Commun       Date:  2007-12-25       Impact factor: 2.459

Review 10.  Malarial proteases and host cell egress: an 'emerging' cascade.

Authors:  Michael J Blackman
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.